A detailed history of Farther Finance Advisors, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,497 shares of DVAX stock, worth $19,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,497
Previous 1,490 0.47%
Holding current value
$19,505
Previous $16.6 Million 0.29%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$10.05 - $11.61 $70 - $81
7 Added 0.47%
1,497 $16.7 Million
Q1 2024

May 13, 2024

BUY
$11.7 - $14.98 $17,000 - $21,765
1,453 Added 3927.03%
1,490 $18.7 Million
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $484 - $554
37 New
37 $517,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.65B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.